Ou J

No ORCID on file · 8 papers in corpus · active 2013-2025

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
article 2025

Wen Zhao,1 Zeting Li,2 Jianping Ou1 1Center for Reproductive Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Endocrinology, The Seventh Affiliated Hospital, S…

other 2025
International journal of women's health ·doi:10.2147/IJWH.S540774

PURPOSE: This mendelian randomization (MR) study aimed to investigate whether endometriosis, overall and stratified by stage (I/II vs III/IV), confers causal effects on adverse pregnancy and perinatal outcomes. METHODS: Exposure data came …

2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1642369

Polycystic ovary syndrome (PCOS) is a major factor in female infertility. The global burden of PCOS has generally been neglected due to insufficient data. This study aims to comprehensively assess the burden of PCOS among females aged 10-54…

2025
EBioMedicine ·doi:10.1016/j.ebiom.2024.105514

BackgroundPreimplantation genetic testing for chromosomal structural rearrangements (PGT-SR) has been widely utilized to select euploid embryos in patients carrying balanced chromosomal rearrangements (BCRs) by chromosome copy number analys…

2024
Nature communications ·doi:10.1038/s41467-024-46700-2

Ovarian cancer, a group of heterogeneous diseases, presents with extensive characteristics with the highest mortality among gynecological malignancies. Accurate and early diagnosis of ovarian cancer is of great significance. Here, we presen…

article 2023
Women & health ·doi:10.1080/03630242.2023.2296522

Endometriosis (EMS) is a chronic inflammatory disorder of high incidence that causes serious reproductive consequences. High estrogen production is a consistently observed endocrine feature of EMS. The present study aims to probe the molecu…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.875779

ObjectiveTo evaluate the clinical outcomes and maternal-neonatal safety of gonadotropin releasing hormone antagonist (GnRH-ant) and gonadotropin releasing hormone agonist (GnRH-a) protocols.MethodsA total of 2505 women undergoing their firs…

2013
International journal of clinical and experimental pathology

BackgroundDiagnosis of ovarian cancer is often delayed because of subtle symptoms and a lack of a specific, sensitive test useful for the general population. The majority of cases are diagnosed at late stages, after the tumor has metastasiz…